Fully automated viability and toxicity screening—A reliable all‐in‐one attempt

Abstract Background The CRISPR/Cas9 technology is nowadays a common tool for genome editing to achieve new insights into, for example, diagnostics and therapeutics in cancer and genetic disorders. Cell proliferation and anticancer drug response studies are widely used to evaluate the impact of editi...

全面介紹

書目詳細資料
發表在:Cancer Medicine
Main Authors: Victoria Liedtke, Romano Weiss, Anastasia Skifov, Stefan Rödiger, Lysann Schenk
格式: Article
語言:英语
出版: Wiley 2024-06-01
主題:
在線閱讀:https://doi.org/10.1002/cam4.7392
_version_ 1875641935075475456
author Victoria Liedtke
Romano Weiss
Anastasia Skifov
Stefan Rödiger
Lysann Schenk
author_facet Victoria Liedtke
Romano Weiss
Anastasia Skifov
Stefan Rödiger
Lysann Schenk
author_sort Victoria Liedtke
collection DOAJ
container_title Cancer Medicine
description Abstract Background The CRISPR/Cas9 technology is nowadays a common tool for genome editing to achieve new insights into, for example, diagnostics and therapeutics in cancer and genetic disorders. Cell proliferation and anticancer drug response studies are widely used to evaluate the impact of editing. However, these assays are often time‐consuming, expensive, and reproducibility is an issue. To overcome this, we developed a fast and cheap assay that combines a fully automated multispectral fluorescence microscopy platform with a nuclei staining and open‐source software analysis. Methods Here, we generated different LEDGF/p75 model cell lines to validate the effect on proliferation and chemosensitivity. Therefore, a fast protocol for an optimized all‐in‐one attempt for cytotoxicity screenings and proliferation analysis of adherent cells in a 96‐well plate format was established using differential staining with two fluorescent dyes (Hoechst 33342 and propidium iodide) for live/dead cell discrimination. Subsequently, an automated cell nuclei count and analysis were performed using bioimage informatics. Results With the new established assay technology, up to 50,000 cells/well can be detected and analyzed in a 96‐well plate, resulting in a fast and accurate verification of viability and proliferation with consistency of 98% compared to manual counting. Our screening revealed that LEDGF depletion using CRISPR/Cas9 showed a diminished proliferation and chemosensitivity independent of cell line origin. Moreover, LEDGF depletion caused a significant increase in 𝛾H2AX foci, indicating a substantial increase in DNA double strand breaks. LEDGF/p75 overexpression enhanced proliferation and chemoresistance underlining the role of LEDGF in DNA damage response. Conclusion Independent of cancer cell type, LEDGF/p75 is a central player in DNA damage repair and is implicated in chemoresistance. Moreover, our automated fluorescence biosensor technology allowed fast and reliable data acquisition without any fixation or additional washing steps. Additionally, data analysis was implemented using the modular open‐source software that can be adapted as needed.
format Article
id doaj-art-c50d5b22cd29461d8a5aa984038fec8a
institution Directory of Open Access Journals
issn 2045-7634
language English
publishDate 2024-06-01
publisher Wiley
record_format Article
spelling doaj-art-c50d5b22cd29461d8a5aa984038fec8a2026-05-09T03:43:36ZengWileyCancer Medicine2045-76342024-06-011312n/an/a10.1002/cam4.7392Fully automated viability and toxicity screening—A reliable all‐in‐one attemptVictoria Liedtke0Romano Weiss1Anastasia Skifov2Stefan Rödiger3Lysann Schenk4Faculty of Natural Sciences Brandenburg University of Technology Cottbus‐Senftenberg Senftenberg GermanyFaculty of Natural Sciences Brandenburg University of Technology Cottbus‐Senftenberg Senftenberg GermanyFaculty of Natural Sciences Brandenburg University of Technology Cottbus‐Senftenberg Senftenberg GermanyFaculty of Natural Sciences Brandenburg University of Technology Cottbus‐Senftenberg Senftenberg GermanyFaculty of Natural Sciences Brandenburg University of Technology Cottbus‐Senftenberg Senftenberg GermanyAbstract Background The CRISPR/Cas9 technology is nowadays a common tool for genome editing to achieve new insights into, for example, diagnostics and therapeutics in cancer and genetic disorders. Cell proliferation and anticancer drug response studies are widely used to evaluate the impact of editing. However, these assays are often time‐consuming, expensive, and reproducibility is an issue. To overcome this, we developed a fast and cheap assay that combines a fully automated multispectral fluorescence microscopy platform with a nuclei staining and open‐source software analysis. Methods Here, we generated different LEDGF/p75 model cell lines to validate the effect on proliferation and chemosensitivity. Therefore, a fast protocol for an optimized all‐in‐one attempt for cytotoxicity screenings and proliferation analysis of adherent cells in a 96‐well plate format was established using differential staining with two fluorescent dyes (Hoechst 33342 and propidium iodide) for live/dead cell discrimination. Subsequently, an automated cell nuclei count and analysis were performed using bioimage informatics. Results With the new established assay technology, up to 50,000 cells/well can be detected and analyzed in a 96‐well plate, resulting in a fast and accurate verification of viability and proliferation with consistency of 98% compared to manual counting. Our screening revealed that LEDGF depletion using CRISPR/Cas9 showed a diminished proliferation and chemosensitivity independent of cell line origin. Moreover, LEDGF depletion caused a significant increase in 𝛾H2AX foci, indicating a substantial increase in DNA double strand breaks. LEDGF/p75 overexpression enhanced proliferation and chemoresistance underlining the role of LEDGF in DNA damage response. Conclusion Independent of cancer cell type, LEDGF/p75 is a central player in DNA damage repair and is implicated in chemoresistance. Moreover, our automated fluorescence biosensor technology allowed fast and reliable data acquisition without any fixation or additional washing steps. Additionally, data analysis was implemented using the modular open‐source software that can be adapted as needed.https://doi.org/10.1002/cam4.7392automated systembioimage informaticsCRISPR/Cas9cytotoxicityviability
spellingShingle Victoria Liedtke
Romano Weiss
Anastasia Skifov
Stefan Rödiger
Lysann Schenk
Fully automated viability and toxicity screening—A reliable all‐in‐one attempt
automated system
bioimage informatics
CRISPR/Cas9
cytotoxicity
viability
title Fully automated viability and toxicity screening—A reliable all‐in‐one attempt
title_full Fully automated viability and toxicity screening—A reliable all‐in‐one attempt
title_fullStr Fully automated viability and toxicity screening—A reliable all‐in‐one attempt
title_full_unstemmed Fully automated viability and toxicity screening—A reliable all‐in‐one attempt
title_short Fully automated viability and toxicity screening—A reliable all‐in‐one attempt
title_sort fully automated viability and toxicity screening a reliable all in one attempt
topic automated system
bioimage informatics
CRISPR/Cas9
cytotoxicity
viability
url https://doi.org/10.1002/cam4.7392
work_keys_str_mv AT victorialiedtke fullyautomatedviabilityandtoxicityscreeningareliableallinoneattempt
AT romanoweiss fullyautomatedviabilityandtoxicityscreeningareliableallinoneattempt
AT anastasiaskifov fullyautomatedviabilityandtoxicityscreeningareliableallinoneattempt
AT stefanrodiger fullyautomatedviabilityandtoxicityscreeningareliableallinoneattempt
AT lysannschenk fullyautomatedviabilityandtoxicityscreeningareliableallinoneattempt